Jonathan Davies MP: written questions
Jonathan Davies MP: full overview
4 Jul 2024–3 Jul 2025
How these years work
Our reporting years run from 4 July to 3 July, starting with the 2024 general election. They are not official parliamentary sessions. Office costs keep IPSA’s April–March financial years. Records may cover only part of a year; a missing record does not mean no work was done.
Written questions: dates and coverage
- Source checked
- 21 Nov 2026
- Last successful import
- 21 Nov 2026
- Records dated through
- 20 Nov 2026
- Selected period
- Reporting year 1: 4 Jul 2024 to 3 Jul 2025
- Completeness
- Published snapshot: 25,747 records in the source window 23 Aug 2026 to 21 Nov 2026. The published snapshot covers its stated source window. Answers and corrections can appear later; no indexed answer does not prove that none exists.
Understand written questions, dates and answers.
Read what this MP said, asked and contributed in Parliament.
16 published records · newest first.
Written questions
Long Covid: RemdesivirDepartment of Health and Social CareTabled 22 May 2025AnsweredUIN 54513More
Question: To ask the Secretary of State for Health and Social Care, whether his Department has had discussions with the University of Derby on the development of the drug Remdesivir for the treatment of long Covid.
Answer: We are aware of the University of Derby’s study looking at the use of the drug Remdesivir for the treatment of long COVID, however officials have not discussed the study with the research team. The study is being managed by the University of Plymouth’s Pe...
Answered 5 Jun 2025
Original Parliament recordLong Covid: Health ServicesDepartment of Health and Social CareTabled 22 May 2025AnsweredUIN 54512More
Question: To ask the Secretary of State for Health and Social Care, what steps his Department is taking to (a) support people living with long covid, (b) retain the services provided by the long covid clinic and (c) develop systems of treatment and diagnosis to ide
Answer: NHS England has invested £314 million since the start of the pandemic to provide care and support for people with long COVID. This includes establishing specialist clinics throughout England to assess adults, children, and young people who are experiencin...
Answered 5 Jun 2025
Original Parliament recordCoronavirus: VaccinationDepartment of Health and Social CareTabled 16 May 2025AnsweredUIN 52956More
Question: To ask the Secretary of State for Health and Social Care, if his Department will take steps to ensure that non-mRNA covid vaccines are made available via the NHS to people unable to receive mRNA vaccines.
Answer: All vaccines in the United Kingdom must be authorised by the Medicines and Healthcare products Regulatory Agency (MHRA) before they can be placed on the United Kingdom’s market. The updated 2024/25 Novavax (Nuvaxovid) COVID-19 vaccine has not been authori...
Answered 22 May 2025
Original Parliament recordHospital Wards: SecurityDepartment of Health and Social CareTabled 17 Apr 2025AnsweredUIN 46496More
Question: To ask the Secretary of State for Health and Social Care, what guidance NHS England has issued to hospital trusts to ensure appropriate monitoring of individuals entering and leaving hospital wards; and how many reported security incidents relating to una
Answer: NHS England provides no guidance to National Health Service trusts to ensure the appropriate monitoring of individuals entering and leaving hospital wards, and data is not collected on how many reported security incidents relating to unauthorised access t...
Answered 29 Apr 2025
Original Parliament recordNHS: StaffDepartment of Health and Social CareTabled 24 Mar 2025AnsweredUIN 40856More
Question: To ask the Secretary of State for Health and Social Care, what steps his Department is taking to improve (a) trust and (b) accountability on staff complaints in NHS organisations; and what steps he is taking to prevent (i) discrimination and (ii) bullying
Answer: National Health Service staff should have the confidence to speak out and come forward if they have concerns. There is support in place for staff who wish to raise concerns, including a network of more than 1,200 local Freedom to Speak Up Guardians across...
Answered 2 Apr 2025
Original Parliament recordFacial Palsy: Health ServicesDepartment of Health and Social CareTabled 24 Mar 2025AnsweredUIN 40854More
Question: To ask the Secretary of State for Health and Social Care, what steps his Department is taking to (a) engage healthcare professionals in the early diagnosis and treatment of facial palsy and (b) support patients in the days following a facial palsy diagnos
Answer: The provision of care and management for people with facial palsy, also known as Bell’s palsy, is the responsibility of general practices, under local integrated care boards.The National Institute for Health and Care Excellence (NICE) has produced a clini...
Answered 1 Apr 2025
Original Parliament recordBrain: TumoursDepartment of Health and Social CareTabled 11 Mar 2025AnsweredUIN 37460More
Question: To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the potential merits of including nanopore sequencing-based brain tumour methylome classification in the National Genomic Test Directory.
Answer: The Department funded the Cancer 2.0 initiative in 2021, delivered by Genomics England in close partnership with NHS England. The three-year programme demonstrated that nanopore sequencing-based brain tumour classification demonstrates significant promise...
Answered 24 Mar 2025
Original Parliament recordCauda Equina Syndrome: Health ServicesDepartment of Health and Social CareTabled 10 Mar 2025AnsweredUIN 37033More
Question: To ask the Secretary of State for Health and Social Care, what steps his Department is taking to support individuals living with Cauda Equina Syndrome with access to (a) treatment, (b) rehabilitation and (c) financial assistance.
Answer: The Government is committed to improving the lives of those living with rare diseases, such as cauda equina syndrome. The UK Rare Diseases Framework sets out four priorities collaboratively developed with the rare disease community: these include improvin...
Answered 17 Mar 2025
Original Parliament recordNHS: Sick LeaveDepartment of Health and Social CareTabled 27 Feb 2025AnsweredUIN 34506More
Question: To ask the Secretary of State for Health and Social Care, what his Department's policy is on supporting NHS trusts to meet their annual sickness absence targets.
Answer: Data published by NHS England shows that during the month of October 2024, there were 317,167 full time equivalent days lost due to musculoskeletal health issues for National Health Service staff. These account for 13% of all sickness absences over the mo...
Answered 7 Mar 2025
Original Parliament recordNHS: Musculoskeletal DisordersDepartment of Health and Social CareTabled 27 Feb 2025AnsweredUIN 34505More
Question: To ask the Secretary of State for Health and Social Care, how many NHS staff are absent from work due to musculoskeletal health issues; and what assessment he has made of the potential merits of fast-tracking treatment for such staff.
Answer: Data published by NHS England shows that during the month of October 2024, there were 317,167 full time equivalent days lost due to musculoskeletal health issues for National Health Service staff. These account for 13% of all sickness absences over the mo...
Answered 7 Mar 2025
Original Parliament recordPrescriptions: Fees and ChargesDepartment of Health and Social CareTabled 27 Feb 2025AnsweredUIN 34504More
Question: To ask the Secretary of State for Health and Social Care, how many prescription prepayment certificates have been issued in (a) England and (b) Mid Derbyshire in the last five years.
Answer: Prescription Prepayment Certificates (PPCs) are issued by the NHS Business Services Authority (NHSBSA) on behalf of the Department. The following table shows the number of three and 12 month PPCs issued in England over the last five years, as well as the ...
Answered 7 Mar 2025
Original Parliament recordGeneral Practitioners: PharmacyDepartment of Health and Social CareTabled 27 Feb 2025AnsweredUIN 34503More
Question: To ask the Secretary of State for Health and Social Care, what assessment he has made of the adequacy of communication systems between GP surgeries and pharmacies.
Answer: The Government recognises the importance of effective communication between general practice (GP) surgeries and pharmacies, to ensure safe and coordinated patient care. Over recent years, several digital initiatives have been introduced to reduce the reli...
Answered 11 Mar 2025
Original Parliament recordGlioblastoma: ResearchDepartment of Health and Social CareTabled 27 Feb 2025AnsweredUIN 34502More
Question: To ask the Secretary of State for Health and Social Care, whether he has made an assessment with Cabinet colleagues of the impact of patent lengths on research into treatments for glioblastoma.
Answer: Intellectual property rights in the United Kingdom are not condition specific. The Government considers the UK’s current patent system to strike the right balance between incentivising research and innovation and supporting access to medicines for the Nat...
Answered 10 Mar 2025
Original Parliament recordProstate Cancer: ScreeningDepartment of Health and Social CareTabled 11 Dec 2024AnsweredUIN 19562More
Question: To ask the Secretary of State for Health and Social Care, what assessment he has made of the adequacy of the availability of prostate cancer screenings.
Answer: Screening for prostate cancer is currently not recommended by the UK National Screening Committee (UK NSC). This is because of the inaccuracy of the current best test, called the Prostate Specific Antigen (PSA). A PSA-based screening programme could harm ...
Answered 16 Dec 2024
Original Parliament recordADHD: DrugsDepartment of Health and Social CareTabled 27 Nov 2024AnsweredUIN 16685More
Question: To ask the Secretary of State for Health and Social Care, what steps he is taking to tackle shortages of ADHD medication.
Answer: The Department has been working hard with industry and NHS England to help resolve supply issues with some attention deficit hyperactivity disorder (ADHD) medicines, which are affecting the United Kingdom and other countries around the world. As a result ...
Answered 4 Dec 2024
Original Parliament recordSipavibart: ImmunosuppressionDepartment of Health and Social CareTabled 23 Oct 2024AnsweredUIN 10928More
Question: To ask the Secretary of State for Health and Social Care, whether Sipavibart can be provided through the NHS to immunosuppressed people.
Answer: Decisions on the routine availability of licensed medicines for National Health Service patients in England are made on the basis of recommendations by the National Institute for Health and Care Excellence (NICE). NICE plays an important role in ensuring ...
Answered 28 Oct 2024
Original Parliament record
Explore activity by topic or department
Written questions by answering department
4 Jul 2024–3 Jul 2025. One record per UIN and tabled date; the named department is not a measure of answer quality.
View as listWhat this shows and doesn't show
Published records only — not a full account of an MP’s work. How we work →